Here's a worthwhile read:
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial | Nature Medicine
Oncolytic Virus ? Check.
Pembro (Keytruda) Combination ? Check.
Durable responses ? Check.
Complete responses ? Check.
Median time to response, 3 months.
All very interesting and adds weight to the argument that Immunotherapy combinations with Oncolytic viruses may be effective treatments for cancer. Whilst some may see this as the competition, i prefer to look at it as real world validation that also informs the work Imugene is undertaking.
GLTAH.
Competitive landscape, page-239
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.5¢ | $1.012M | 18.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 590122 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1408449 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |